Search
Clinafloxacin
go.drugbank.com/drugs/DB14025ExperimentalClinafloxacin is a fluoroquinolone antibacterial currently under research. It has been proven to present good antibiotic properties. However, its approval and release have been halted due to the presence of serious side effects.
Categories: Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 CYP2C19 InhibitorsMadecassic acid
go.drugbank.com/drugs/DB14037InvestigationalCategories: Cytochrome P-450 CYP2C9 Inhibitors, Cytochrome P-450 CYP2D6 InhibitorsValinomycin
go.drugbank.com/drugs/DB14057ExperimentalA cyclododecadepsipeptide ionophore antibiotic produced by Streptomyces fulvissimus and related to the enniatins. It is composed of 3 moles each of L-valine, D-alpha-hydroxyisovaleric acid, D-valine, and L-lactic acid linked alternately ...
Categories: P-glycoprotein inhibitors, P-glycoprotein substratesHycanthone
go.drugbank.com/drugs/DB14061ExperimentalPotentially toxic, but effective antischistosomal agent, it is a metabolite of LUCANTHONE. Hycanthone was approved by the FDA in 1975 but is no longer used.
Categories: P-glycoprotein inhibitorsConcanamycin A
go.drugbank.com/drugs/DB14062ExperimentalConcanamycin A is an H+-ATPase (vacuolar) inhibitor.
Categories: P-glycoprotein inhibitorsTetrandrine
go.drugbank.com/drugs/DB14066InvestigationalCategories: Cytochrome P-450 Substrates, P-glycoprotein inhibitorsDofequidar
go.drugbank.com/drugs/DB14067InvestigationalDofequidar is an antineoplastic agent.
Categories: P-glycoprotein inhibitorsDesmethylsertraline
go.drugbank.com/drugs/DB14071ExperimentalDesmethylsertraline is a metabolite of sertraline.
Categories: P-glycoprotein inhibitorsReversin 121
go.drugbank.com/drugs/DB14072ExperimentalReversin 121 is a hydrophobic peptide chemosensitizer that can reverse P-glycoprotein-mediated multidrug resistance.
Categories: P-glycoprotein inhibitors